Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-08-004299
Filing Date
2008-07-15
Accepted
2008-07-15 16:46:43
Documents
1
Period of Report
2008-07-15

Document Format Files

Seq Description Document Type Size
1 c54295_ex.html 4  
1 c54295_ex.xml 4 2921
  Complete submission text file 0000930413-08-004299.txt   4701
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELITE PHARMACEUTICALS INC 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 201-750-2646
BEHL CHARAN (Reporting) CIK: 0001350693 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15697 | Film No.: 08953182